201 related articles for article (PubMed ID: 25635886)
1. Crooke's cell tumors of the pituitary.
Di Ieva A; Davidson JM; Syro LV; Rotondo F; Montoya JF; Horvath E; Cusimano MD; Kovacs K
Neurosurgery; 2015 May; 76(5):616-22. PubMed ID: 25635886
[TBL] [Abstract][Full Text] [Related]
2. Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma.
George DH; Scheithauer BW; Kovacs K; Horvath E; Young WF; Lloyd RV; Meyer FB
Am J Surg Pathol; 2003 Oct; 27(10):1330-6. PubMed ID: 14508394
[TBL] [Abstract][Full Text] [Related]
3. Crooke's hyalinization in silent corticotroph adenoma: report of two cases.
Roncaroli F; Faustini-Fustini M; Mauri F; Asioli S; Frank G
Endocr Pathol; 2002; 13(3):245-9. PubMed ID: 12446925
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical characteristics of Crooke's cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review.
Zhu D; Wang Z; Tian T; Wu X; He D; Zhu Y; Liu D; Wang H
Front Endocrinol (Lausanne); 2022; 13():947085. PubMed ID: 36060980
[TBL] [Abstract][Full Text] [Related]
5. Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility.
Oldfield EH; Vance ML; Louis RG; Pledger CL; Jane JA; Lopes MB
J Clin Endocrinol Metab; 2015 Aug; 100(8):3165-71. PubMed ID: 26147609
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators in an aggressive pituitary Crooke's cell adenoma.
Kovacs K; Diep CC; Horvath E; Cusimano M; Smyth H; Lombardero CC; Scheithauer BW; Lloyd RV
Can J Neurol Sci; 2005 Nov; 32(4):540-5. PubMed ID: 16408589
[TBL] [Abstract][Full Text] [Related]
7. Aggressive Pituitary Tumor with Crooke's Cells and Invasion of the Posterior Fossa.
Cortez GM; Monteiro A; Agnoletto G; Bit-Ivan EN; Sauvageau E; Hanel RA
World Neurosurg; 2020 Jun; 138():530-534.e1. PubMed ID: 32145418
[TBL] [Abstract][Full Text] [Related]
8. Successful reduction of ACTH secretion in a case of intractable Cushing's disease with pituitary Crooke's cell adenoma by combined modality therapy including temozolomide.
Tanaka S; Yamamoto M; Morita M; Takeno A; Kanazawa I; Yamaguchi T; Yamada S; Inoshita N; Oki Y; Kurosaki M; Sugimoto T
Endocr J; 2019 Aug; 66(8):701-708. PubMed ID: 31130573
[TBL] [Abstract][Full Text] [Related]
9. Pituitary pathology in Cushing's disease.
Saeger W; Geisler F; Lüdecke DK
Pathol Res Pract; 1988 Sep; 183(5):592-5. PubMed ID: 3237549
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke's cell morphology.
Garbicz F; Mehlich D; Rak B; Sajjad E; Maksymowicz M; Paskal W; Zieliński G; Włodarski PK
Pituitary; 2017 Aug; 20(4):450-463. PubMed ID: 28432562
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic correlations of silent corticotroph adenomas of the pituitary: report of four cases and literature review.
Sahli R; Christ ER; Seiler R; Kappeler A; Vajtai I
Pathol Res Pract; 2006; 202(6):457-64. PubMed ID: 16497445
[TBL] [Abstract][Full Text] [Related]
12. Massive Crooke's hyalinization in corticotroph cell adenomas of the human pituitary. A histological, immunocytological, and electron microscopic study of three cases.
Felix IA; Horvath E; Kovacs K
Acta Neurochir (Wien); 1981; 58(3-4):235-43. PubMed ID: 6172012
[TBL] [Abstract][Full Text] [Related]
13. The role of Crooke's changes in recurrence and remission after gamma knife radiosurgery.
Cordeiro D; Xu Z; Nasser M; Lopes B; Vance ML; Sheehan J
J Neurooncol; 2019 Mar; 142(1):171-181. PubMed ID: 30607704
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide therapy for aggressive pituitary Crooke's cell corticotropinoma causing Cushing's Disease - a case report with literature review.
Gilis-Januszewska A; Wilusz M; Pantofliński J; Turek-Jabrocka R; Sokołowski G; Sowa-Staszczak A; Kluczyński Ł; Pach D; Zieliński G; Hubalewska-Dydejczyk A
Endokrynol Pol; 2018; 69(3):306-312. PubMed ID: 29319131
[TBL] [Abstract][Full Text] [Related]
15. Long-term complete remission of Crooke's corticotropinoma after temozolomide treatment.
Kurowska M; Tarach JS; Malicka J; Zieliński G; Maksymowicz M; Denew P
Endokrynol Pol; 2016; 67(5):526-533. PubMed ID: 27828691
[TBL] [Abstract][Full Text] [Related]
16. High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.
Takeshita A; Inoshita N; Taguchi M; Okuda C; Fukuhara N; Oyama K; Ohashi K; Sano T; Takeuchi Y; Yamada S
Eur J Endocrinol; 2009 Oct; 161(4):553-9. PubMed ID: 19589911
[TBL] [Abstract][Full Text] [Related]
17. Multimodality treatment for invasive pituitary adenomas.
Hornyak M; Couldwell WT
Postgrad Med; 2009 Mar; 121(2):168-76. PubMed ID: 19332975
[TBL] [Abstract][Full Text] [Related]
18. Silent Crooke's cell corticotroph adenoma of the pituitary gland presenting as delayed puberty.
Giri D; Roncaroli F; Sinha A; Didi M; Senniappan S
Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28458905
[TBL] [Abstract][Full Text] [Related]
19. Absence of peritumoral Crooke's change is associated with recurrence in surgically treated Cushing's disease.
Hague K; Post KD; Morgello S
Surg Neurol; 2000 Jan; 53(1):77-81. PubMed ID: 10697237
[TBL] [Abstract][Full Text] [Related]
20. Silent corticotroph adenomas: further clinical and pathological observations.
Lopez JA; Kleinschmidt-Demasters Bk Bk; Sze CI; Woodmansee WW; Lillehei KO
Hum Pathol; 2004 Sep; 35(9):1137-47. PubMed ID: 15343517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
